Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 221
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03184402 | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2) | ||
| NCT04003441 | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers | ||
| NCT04535856 | Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients | ||
| NCT02346045 | Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension | ||
| NCT04477369 | Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers | ||
| NCT04782505 | Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers | ||
| NCT06119958 | Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects | ||
| NCT04064073 | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study) | ||
| NCT02502721 | A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152 | ||
| NCT05926414 | To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT02568150 | Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines | ||
| NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
| NCT02947815 | Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm | ||
| NCT02704559 | Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT01423526 | A Single Dose Study of DWP10292 in Healthy Male Subjects | ||
| NCT03005223 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers | ||
| NCT06419816 | Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus | ||
| NCT05321732 | The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults | ||
| NCT04278391 | Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers | ||
| NCT04490434 | Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs | ||
| NCT01629199 | Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus | ||
| NCT05184179 | Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab | ||
| NCT04014023 | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
| NCT04888728 | To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers | ||
| NCT05812404 | Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects | ||
| NCT06354127 | DWP450 for Treating Moderate to Severe Glabellar Lines | ||
| NCT05889143 | A Study to Evaluate the Efficacy and Safety of CREZET Tablet | ||
| NCT05466643 | A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus | ||
| NCT05207176 | Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities | ||
| NCT01651858 | Nurigra Chewable Tablet in Healthy Adult Male Volunteers | ||
| NCT05889026 | The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity | ||
| NCT05389215 | Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF | ||
| NCT04713176 | Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients | ||
| NCT05574374 | Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects | ||
| NCT01713920 | Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM | ||
| NCT03487562 | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects | ||
| NCT06141980 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
| NCT02947139 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers | ||
| NCT02415777 | Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction | ||
| NCT05376930 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. | ||
| NCT05192395 | A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers | ||
| NCT01099891 | The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients | ||
| NCT01629212 | Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome | ||
| NCT06272630 | Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease | ||
| NCT06606093 | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients | ||
| NCT04767815 | To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers | ||
| NCT03947489 | Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions | ||
| NCT07190391 | Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis | ||
| NCT03016494 | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects |
